DSS stock pops on licensing deal with ProPhase Labs (NYSE:DSS)
DSS (DSS) shares popped around 17% after the company announced on Thursday the licensing of Impact BioMedical''s Linebacker portfolio to ProPhase Labs (PRPH).Global BioLife, a subsidiary…
DSS stock pops on licensing deal with ProPhase Labs (NYSE:DSS)
DSS (DSS) shares popped around 17% after the company announced on Thursday the licensing of Impact BioMedical''s Linebacker portfolio to ProPhase Labs (PRPH).Global BioLife, a subsidiary…